After addition of anxiety as qualifying condition, 60.26 percent of certifications were for anxiety
Prevalence of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids vaping higher for girls than boys
Past-year mental health treatment and community supervision involvement tied to receiving treatment
Notable shifts seen among those with higher income and certain clinical conditions
Vaping and dabbing are the most prevalent routes of use among persons aged 18 to 24 years
Compared with those with all-cause hospital-based care and the general population, risk increased for those with cannabis use-based care
Review shows benefits for social responsiveness, disruptive behavior, and anxiety
Additionally, specific symptom improvement seen
Commercial administrative claims data show slight increase in annual prevalence from 2015 to 2020